Segmental acquisition method for stationary objects in (18)F-fluorodeoxyglucose positron emission tomography tests

Jpn J Radiol. 2010 Oct;28(8):591-601. doi: 10.1007/s11604-010-0482-5. Epub 2010 Oct 24.

Abstract

Purpose: We investigated whether images of stationary objects obtained by segmental acquisition with positron emission tomography using 2-deoxy-2-[(18)F]-fluoro-D: -glucose (FDG-PET) are of a quality equivalent to those obtained by conventional continuous acquisition.

Materials and methods: Phantoms filled with FDG and mid-abdominal regions of 18 patients who underwent FDG-PET tests were imaged by both continuous and segmental acquisition methods. The total acquisition time was set to 3 min; in the segmental acquisition mode, imaging for 15 s was repeated 12 times. Segmental images (SIs) obtained by superimposition of the reconstructed images were compared quantitatively and visually with continuous images (CIs).

Results: In all the phantom and clinical studies, SIs were never worse than CIs. The variances of the background counts of SIs were 9.8% and 13.0% less those of CIs in phantom and clinical studies, respectively. Visual assessments showed that SIs provided better detection of hot areas and superior image quality when compared to CIs.

Conclusion: For stationary objects, the quality of images obtained by the segmental method is equivalent to that of images obtained conventionally by continuous acquisition. Moreover, under some conditions SIs provide better results than CIs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Back / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Muscle, Skeletal / diagnostic imaging*
  • Neoplasms / diagnostic imaging*
  • Phantoms, Imaging
  • Positron-Emission Tomography / methods*
  • Radiographic Image Interpretation, Computer-Assisted
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18